Citizens Reiterates Market Outperform on Oracle, $285 PT
Citizens analyst Patrick Walravens reiterated a Market Outperform rating and $285 price target on Oracle (NYSE: ORCL).
“We maintain our Market Outperform rating and $285 price target on Oracle Corporation after the company reported generally better-than-expected F1Q27 results, with non-GAAP EPS of $1.92 (consensus $1.74), operating margin of 42.5% (consensus 40.9%) on revenue of $19.3B (consensus $19.1B), up 30% y/y versus 21% last quarter, impressive OCI growth of 121% y/y, up from 93% last quarter, RPO of $664B, up $209B y/y and ahead of consensus of $618B, and CapEx of $28.5B, higher than expected, while operating cash flow was $23B and free cash flow was negative $5B.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
